Evaluation of the Impact of Advanced Glycation End-Products on Peripheral Neuropathy Outcomes in Type 2 Diabetes

<b>Background</b>: Type 2 diabetes (T2DM) affects over 500 million people worldwide, and over 50% of this group experience the most common complication, diabetic peripheral neuropathy (DPN). The presence of advanced glycation end-products (AGEs) has been linked with the development of DP...

Full description

Bibliographic Details

Published in:	Biomedicines
Main Authors:	Indumathi Singh, Tushar Issar, Ann M. Poynten, Kerry-Lee Milner, Arun V. Krishnan, Roshan Dhanapalaratnam
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Subjects:	advanced glycation end-products diabetic peripheral neuropathy skin autofluorescence and advanced glycation end-products
Online Access:	https://www.mdpi.com/2227-9059/12/11/2518